The Self-Injections Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The self-injections market has seen substantial growth over the years. The market size has increased from $9.69 billion in 2024 to $10.3 billion in 2025, at a Compound Annual Growth Rate (CAGR) of 6.3%. The historical growth trend in the Self-Injections market is steadily upward.
By 2029, the Self-Injections market is projected to expand to $14.13 billion. The working growth rate during this period is expected to be at a Compound Annual Growth Rate (CAGR) of 8.2%.
Download Your Free Sample of the 2025 Self-Injections Market Report and Uncover Key Trends Now!The key drivers in the self-injections market are:
• Pandemic impact leading to increased demand for remote treatments
• Expansion into emerging markets where self-injections are less common
• Evolving patient-centric healthcare norms that favor self-care methods like self-injections
• Advancements in drug delivery mechanisms, potentially including self-injection methods.
The self-injections market covered in this report is segmented –
1) By Type: Devices, Formulations
2) By Route Of Administration: Skin, Circulatory Or Musculoskeletal, Organs, Central Nervous System
3) By Dosage: Single Dose, Multi Dose
4) By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications
5) By Distribution Channel: Hospitals Pharmacies, Clinics, Chemist, Online Pharmacies
The key trends in the self-injections market are:
• Smart technology integration is becoming an important trend in the self-injections market.
• There is an evident rise in the usage of biologics in this sector.
• The adoption of miniaturization and wearable devices is a significant emerging trend.
• The self-injection market is also experiencing enhanced safety features and increasing adoption of autoinjectors.
Major companies in the self-injections market are:
• AbbVie Inc.
• Antares Pharma Inc.
• Baxter International Inc.
• Bayer AG
• Becton Dickinson and Company
• Bristol-Myers Squibb Company
• Credence MedSystems Inc.
• Dali Medical Devices Ltd.
• Eli Lilly and Company
• Enable Injections Inc.
• Gerresheimer AG
• Insulet Corporation
• Merck & Co. Inc.
• Owen Mumford Limited
• Pfizer Inc.
• PharmaJet Inc.
• Recipharm AB
• Schott AG
• SHL Group Limited
• Terumo Corporation
• West Pharmaceutical Services Inc.
• Wilhelm Haselmeier GmbH & Co. KG
• Ypsomed Holding AG
• APTAR PHARMA INDIA PVT LTD
• Bespak Europe Ltd.
• Bioject Medical Technologies Inc.
• Catalent Inc.
• Crossject SA
• Injex Pharma AG
• Medeca Pharma AB
• Medimop Medical Projects Ltd.
• Mylan N.V.
• Nemera Development S.A.
• Noble Medical Inc.
North America was the largest region in the self-injections market in 2024